Success Metrics

Active Trials
3(100%)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_4
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

recruiting3100%

Recent Activity

3 active trials
Showing 3 of 3
recruitingphase_4

Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease

NCT05924425
recruitingnot_applicable

Biomarkers of Sleep-wake Cycle in Prodromal Alzheimer's Disease: Role in Cognitive Decline?

NCT05629871
recruitingnot_applicable

Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease

NCT05649514

Clinical Trials (3)

Showing 3 of 3 trials
NCT05924425Phase 4

Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease

Recruiting
NCT05629871Not Applicable

Biomarkers of Sleep-wake Cycle in Prodromal Alzheimer's Disease: Role in Cognitive Decline?

Recruiting
NCT05649514Not Applicable

Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3